▲ SURGE

Entera Bio Ltd.

+91.2%
ENTXNASDAQHealthcare2026-07-27
3.92
Close
2.05
Prev Close
+91.22%
Change
504.1x
Vol Ratio

Why It Surged

2026년 5월 10일, Entera Bio는 중동 지역의 지정학적 긴장 고조로 인해 운영 리스크가 상승했다.

  • ·2026년 5월 10일, Entera Bio는 중동 지역의 지정학적 긴장 고조로 인해 운영 리스크가 상승했다.
  • ·2026년 6월 22일, Entera Bio는 자사의 임상 3상 등록 프로토콜에 대해 FDA로부터 긍정적인 피드백을 받았다.

Related News

Entera Bio Faces Elevated Operational Risks Amid Escalating Middle East Geopolitical Tensions
Tipranks2026-05-10
Reported Earlier: Entera Bio Receives FDA's Positive Feedback For Its Phase 3 Registrational Protocol For
Benzinga2026-06-22
INmune Bio shares are trading higher after the company said it formally submitted its pre-submission package for CORDStrom with the UK's Medicines and Healthcare Products Regulatory Agency. - INmune Bio (NASDAQ:INMB)
Benzinga2026-02-10
Intactis Bio Unveils Biostack Alpha to Showcase Data-Center-Ready Biocomputing
Tipranks2026-07-21
Enanta Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial of EDP-978, an Oral, Once-Daily KIT Inhibitor, in Development for the Treatment of Urticaria
Weeklyvoice2026-04-13

Technical Analysis

Signals
BB Upper BreakOverboughtMACD BullishAbove SMA20
Key Indicators
90.42RSI (14)
1.91SMA 20
0.91Bollinger Lower
2.92Bollinger Upper
1.91Bollinger Mid
0.31MACD
0.18MACD Signal
0.14MACD Hist
View CompanyBack to Surge Stocks
Entera Bio Ltd. Surged +91.2% on 2026-07-27 — Analysis | Alpha Lenz